These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25975416)

  • 1. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
    Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
    Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer.
    Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
    Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
    Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
    Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.
    Chen ZY; Raghav K; Lieu CH; Jiang ZQ; Eng C; Vauthey JN; Chang GJ; Qiao W; Morris J; Hong D; Hoff P; Tran H; Menter DG; Heymach J; Overman M; Kopetz S
    Br J Cancer; 2015 Mar; 112(6):1088-97. PubMed ID: 25688736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
    Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
    J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.
    Bortolin MT; Tedeschi R; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    Cytokine; 2012 Oct; 60(1):90-5. PubMed ID: 22795293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies.
    Patel GS; Ullah S; Beeke C; Hakendorf P; Padbury R; Price TJ; Karapetis CS
    Cancer Med; 2015 Oct; 4(10):1461-71. PubMed ID: 26211512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.
    Spindler KL; Appelt AL; Pallisgaard N; Andersen RF; Brandslund I; Jakobsen A
    Int J Cancer; 2014 Dec; 135(12):2984-91. PubMed ID: 24798213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
    Jary M; Lecomte T; Bouché O; Kim S; Dobi E; Queiroz L; Ghiringhelli F; Etienne H; Léger J; Godet Y; Balland J; Lakkis Z; Adotevi O; Bonnetain F; Borg C; Vernerey D
    Int J Cancer; 2016 Nov; 139(10):2325-35. PubMed ID: 27472156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab.
    Zhu L; Liu B; Zhao Y; Liu L; Yang C; Yang Y; Zhong H
    J Cancer Res Ther; 2014 Dec; 10 Suppl():246-51. PubMed ID: 25693928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
    Golan T; Urban D; Berger R; Lawrence YR
    Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
    Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
    Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy.
    Liu YL; Xu HT; Jiang SX; Yang YM; Cui BB
    J Surg Oncol; 2014 Mar; 109(3):234-8. PubMed ID: 24449194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
    Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
    World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.
    Xie QK; Chen P; Hu WM; Sun P; He WZ; Jiang C; Kong PF; Liu SS; Chen HT; Yang YZ; Wang D; Yang L; Xia LP
    J Transl Med; 2018 Oct; 16(1):273. PubMed ID: 30286769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.